Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
11,823,764
-
Total 13F shares
-
5,123,397
-
Share change
-
+1,090,282
-
Total reported value
-
$143,404,590
-
Price per share
-
$27.99
-
Number of holders
-
40
-
Value change
-
+$33,701,621
-
Number of buys
-
23
-
Number of sells
-
11
Institutional Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) as of Q1 2025
As of 31 Mar 2025,
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,123,397 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, Frazier Life Sciences Management, L.P., SAMSARA BIOCAPITAL, LLC, ADAMS STREET PARTNERS LLC, MILLENNIUM MANAGEMENT LLC, Nantahala Capital Management, LLC, Woodline Partners LP, Opaleye Management Inc., and Blue Owl Capital Holdings LP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.